HIV-1 gp120 Protein Activates Cyclin-Dependent Kinase 1, a Possible Link to Central Nervous System Cell Death

Adonira Saro, Zhaolin Gao, Piniel Alphayo Kambey, Min Li, Jufang HuangViruses 2022 · DOI

TL;DR

This study investigates the molecular mechanisms behind HIV-1-associated neurocognitive disorder (HAND), focusing on the viral protein gp120. Researchers found that gp120 induces neuronal cell death and apoptosis in PC12 cells, and identified Cyclin-Dependent Kinase 1 (CDK1) as a key upregulated gene potentially mediating this damage. This discovery offers a potential molecular signature for HAND and suggests CDK1 as a therapeutic target.

What Problem Does This Paper Address?

HIV-1 infection can lead to a range of neurological complications, collectively known as HIV-associated neurocognitive disorder (HAND). While it's known that the HIV-1 envelope protein gp120 plays a significant role in the pathogenesis of HAND, the precise molecular mechanisms by which it causes neuronal damage and death remain unclear. This lack of understanding hinders the development of effective treatments for this persistent complication of HIV infection. This paper aims to elucidate these mechanisms by identifying specific molecular pathways and genes involved in gp120-induced neurotoxicity.

Methods

The researchers employed a multi-pronged approach:

  • Cell Culture and Transfection: PC12 cells, a common neuronal cell line, were used. They were transfected with a plasmid expressing HIV-1 gp120 to mimic its presence in the brain.
  • Apoptosis Assays: To confirm cell death, they used:
  • PI Staining: To assess cell membrane integrity.
  • CCK8 Assay: To measure cell viability.
  • TUNEL Assay: To detect DNA fragmentation, a hallmark of apoptosis.
  • Western Blotting: To analyze the expression levels of key apoptosis-related proteins like cleaved caspase-3 and Bcl2.
  • Omics Analyses:
    • RNA Transcriptomics: To identify changes in gene expression in gp120-transfected cells.
  • Mass Spectrometry (Proteomics): To identify changes in protein expression.
  • Bioinformatics and Data Integration:
    • Venn Diagrams: To find overlapping genes and proteins between transcriptomics and proteomics datasets.
  • Gene Ontology (GO) and KEGG Pathway Analysis: To categorize the functions and pathways of differentially expressed genes.
  • Public Database Analysis: The GSE35864 dataset from the Gene Expression Omnibus (GEO) was analyzed to compare gene expression in postmortem brain samples from individuals with HIV-associated dementia versus normal controls.
  • Quantitative Polymerase Chain Reaction (qPCR): To validate the expression levels of selected candidate genes.
  • Pharmacological Inhibition: Roscovitine, a known CDK1 inhibitor, was used to assess its effect on gp120-induced apoptosis.

Datasets

  • In-house Data: Data generated from PC12 cells transfected with HIV-1 gp120 and control cells. This includes RNA sequencing, mass spectrometry, and various cell-based assay results.
  • Publicly Available Dataset: The GSE35864 dataset from the Gene Expression Omnibus (GEO) database was utilized. This dataset contains gene expression data from postmortem brain samples of individuals with HIV-associated dementia and normal controls.

Key Insights and Ideas

  • gp120 Directly Induces Neuronal Apoptosis: The study provides strong evidence that gp120, even without the entire virus, can directly trigger programmed cell death (apoptosis) in neuronal cells. This is a crucial finding as it isolates the effect of this specific viral protein.
  • CDK1 as a Central Player: The research highlights Cyclin-Dependent Kinase 1 (CDK1) as a significantly upregulated gene and protein in both the in vitro gp120 model and in human brain samples from individuals with HAND. This suggests CDK1 is a key mediator of gp120-induced neurotoxicity.
  • Cell Cycle Dysregulation Link: The transcriptomic analysis revealed that many genes affected by gp120 are involved in cell division and the cell cycle. This points to a potential mechanism where gp120 disrupts normal cell cycle progression, leading to cell death.
  • Therapeutic Potential of CDK1 Inhibition: The successful attenuation of gp120-induced apoptosis by Roscovitine, a CDK1 inhibitor, opens up a promising avenue for therapeutic intervention in HAND.

Key Results

  • Apoptosis Confirmation: gp120 transfection in PC12 cells led to reduced cell viability, increased DNA fragmentation (TUNEL assay), and altered expression of apoptosis markers (increased cleaved caspase-3 and Bax, decreased Bcl2).
  • Transcriptomic and Proteomic Overlap: Integration of RNA sequencing and mass spectrometry data identified 78 overlapping upregulated genes.
  • Top Candidate Genes: Among the upregulated genes, Fut8, Unc13c, Cdk1, Loc100359539, and Hspa2 were identified as top candidates.
  • CDK1 Upregulation in HAND: Analysis of the GSE35864 dataset confirmed that CDK1 is significantly upregulated in brain samples from individuals with HIV-associated dementia compared to controls.
  • CDK1 Inhibition Reverses Apoptosis: Treatment with Roscovitine significantly reduced CDK1 protein levels and attenuated gp120-induced apoptosis markers in PC12 cells.

Limitations and Future Work

  • In Vitro Model: The study primarily uses the PC12 cell line, which is a model system. While valuable, it may not fully recapitulate the complex environment of the human brain. Future work could involve primary neuronal cultures or animal models to further validate these findings.
  • Mechanism of CDK1 Activation: While the study shows CDK1 upregulation, the precise upstream signaling pathways that lead to its activation by gp120 are not fully elucidated. Further research could explore these specific pathways.
  • Broader Therapeutic Strategies: While CDK1 inhibition shows promise, exploring other potential therapeutic targets identified in the omics analyses could also be beneficial.
  • Clinical Translation: The findings provide a strong basis for further investigation into CDK1 as a diagnostic marker and therapeutic target for HAND in clinical settings.

Summary updated

Abstract

Human immunodeficiency virus-1 (HIV-1)-associated neurodegenerative disorder (HAND) is frequently reported in HIV-infected individuals. The gp120 envelope viral protein has been implicated in the pathogenesis of HAND in HIV-1-infected patients; however, its pathogenic mechanism remains unclear. In this study, we first overexpressed gp120 proteins in pc12 cells and used PI staining, a CCK8 assay, a TUNEL assay, and caspase-9/caspase-3-induced apoptosis to ascertain the mediated cell death. Subsequently, the gp120-overexpressed cells were subjected to RNA transcriptomics and mass spectrometry. The obtained results were integrated and validated using a quantitative polymerase chain reaction (qPCR) and the postmortem brain samples with HIV-associated dementia were analyzed against the normal control (using the GSE35864 data set on gene ontology omnibus repository). Upon the integration of the RNA transcriptomic and proteomic results, 78 upregulated genes were revealed. <i>Fut8</i>, <i>Unc13c</i>, <i>Cdk1</i>, <i>Loc100359539</i>, and <i>Hspa2</i> were the top five upregulated genes. Upon the analysis of the GSE35864 data set, the results indicate that <i>Cdk1</i> was upregulated in HIV-associated dementia in comparison to the normal control. Moreover, the protein expression of <i>Cdk1</i> was significantly higher in the gp120 transfected group compared to the normal control and decreased significantly upon inhibition using Roscovitine (a known <i>Cdk1</i> inhibitor). Taken together, our results provide a possible molecular signature of the neurological impairment secondary to HIV glycoprotein 120.
BibTeX
@inproceedings{saro2022hiv,
  author = {Adonira Saro and Zhaolin Gao and Piniel Alphayo Kambey and Min Li and Jufang Huang},
  title = {{HIV-1 gp120 Protein Activates Cyclin-Dependent Kinase 1, a Possible Link to Central Nervous System Cell Death}},
  booktitle = {Viruses},
  year = {2022},
  doi = {10.3390/v14122793},
}
Figure